< Back to latest news & events

Articles

KTN Microbiome Strategic Roadmap

February 2021

Event date: 29th January 2021

KTN Microbiome Strategic Roadmap is now live. The roadmap reviews the landscape of microbiome science and innovation within the UK. The main objective of this document is to raise the visibility of the UK’s world leading microbiome science and enable translation of this science to benefit academic institutions, start-ups, SMEs and larger established companies.

It is a collaborative effort of 74 leading academic and industry scientists, including HGF Partner Craig Thomson as author, supported with contribution from Michelle Davies and Dr Lauris Kemp.

There are 12 distinct sections within the report, which summarise the current state of microbiome research, business and growth opportunities within each sector:

  • Intestinal Microbiome Transfer
  • Live Biotherapeutic Products & other Therapeutic Modalities
  • Personal Care & Hygiene
  • Nutrition & Wellbeing
  • Animal Health & Nutrition
  • AgriFood & Nutrition – Crop & Soil Health
  • Regulatory
  • Manufacturing
  • Biobanking
  • Enabling Technologies
  • Diagnostics
  • Intellectual property

Download the report here

Latest updates

The FoodTech Series #1 | Medicament, functional food, nutritive product in the same claim 1: when your own examples no longer support the “improvement”

            The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they ruled on an opposition …

Read article

A New Era for AI Patents in the UK: Supreme Court Aligns with the EPO

The UK Supreme Court has handed down its long-awaited judgment in Emotional Perception AI Limited (EPAI) vs Comptroller General of Patents, a decision which serves to significantly change the way …

Read article
Event - 23rd - 25th March 2026

HGF are Gold Sponsors of IPBC Europe 2026

HGF are proud sponsors of IPBC Europe 2026, taking place from 23-25 March 2026 at the Pullman Paris Montparnasse. Bringing together patent pioneers, in-house leaders and private practice specialists, IPBC …

Event details
Event - 8th - 11th February 2026

AUTM Meeting 2026

We are attending the AUTM Annual Meeting from 8–11 February, a flagship event bringing together technology transfer professionals from across the globe. AUTM connects innovators, universities, and industry leaders to …

Event details

The Antibody Series #5 | Epitope-defined antibody claims: when “binds to this epitope” becomes a risk of insufficiency

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews decisions made at the EPO; here, they reviewed an appeal in opposition proceedings after the revocation …

Read article

The Deity Shoes case: a question of design activity and the constraints on a designer’s freedom

The footwear brand Deity Shoes sought to enforce their Community Design rights, both registered and unregistered, against Mundorama Confort and Stay Design. However, Mundorama Confort and Stay Design found fault …

Read article

The Antibody Series #4 | pH points in antibody claims: when “same pH ” becomes an addition of matter

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they reviewed a revocation in opposition of a patent relating to …

Read article

The Antibody Series #3 | Antibody code names in claims: why “ACZ885” is not sufficient to define the antibody

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions. In this case, they examined a claim that identified an antibody by an internal …

Read article
See all updates